The U.S. Food and Drug Administration (FDA) has granted traditional approval to Jaypirca (pirobrutinib) for the treatment of ...

ROCHESTER, Minn. — Chemotherapy is usually the first treatment doctors try to treat lymphoma, including the two most common forms: non-Hodgkin and Hodgkin. But alternatives to chemotherapy are ...

The U.S. Food and Drug Administration (FDA) has approved Epkinly (epcoritamab-bysp) plus Revlimid (lenalidomide) and Rituxan (rituximab) for the treatment of patients with relapsed or refractory ...

Roger O' Donnell of The Cure performs at Riot Fest 2023 at Douglass Park in Chicago on Sept. 17. The Cure keyboardist Roger O’Donnell revealed his lymphoma diagnosis in a series of posts Sunday on X ...

Blood Cancer United®, formerly The Leukemia & Lymphoma Society, announced today new scientific grants and investments to continue momentum toward cures and a better quality of life for all people with ...

The Student Visionaries of the Year campaign cultivates teen leadership while advancing Blood Cancer United's mission. The Student Visionaries of the Year campaign cultivates teen leadership while ...

Non-Hodgin's Lymphoma is the seventh most common cancer in the U.S. Some forms of the disease respond well to the treatment, while others are stubborn and aggressive. Now, a new discovery may change ...

Full House’ star Dave Coulier announced he’s been diagnosed with tongue cancer just eight months after he beat non-Hodgkin ...

The Cure’s keyboardist, Roger O’Donnell, has revealed he was diagnosed with a “rare and aggressive” form of lymphoma. O’Donnell, 68, shared the news via a series of X posts on Sunday, September 1, ...

CRANBURY, NJ, Dec. 01, 2025 (GLOBE NEWSWIRE) -- CURE® proudly announces its partnership with Blood Cancer United ®, formerly The Leukemia & Lymphoma Society®, to present the inaugural Blood Cancer ...

The Cure keyboardist Roger O’Donnell revealed his lymphoma diagnosis in a series of posts Sunday on X in honor of September's being Blood Cancer Awareness Month. "In September last year I was ...